Welcome To ChemAnalyst
The prices of Cefaclor in the U.S. import market were stable in early December ****. The steady downstream activity and predictable supply-side performance have resulted in a stability in the market value of Cefaclor. The pharmaceutical manufacturers in the U.S. have continued the routine production runs for cefaclor-containing antibiotics and cough formulations which kept the offtake consistent. The procurement was focused on replenishment rather than accumulation as the buyers have not entered the month with tight inventory. The Chinese producers of Cefaclor have maintained efficient runs and timely export schedules. The port handling and clearance were functional which kept the shipments flow without observing any major material disruption. The alignment between measured buying and consistent selling have kept the Cefaclor market from observing abrupt fluctuation.
The FOB Shanghai offers for Cefaclor have observed an increase by *.** with the export quotation assessed at USD...
We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.

Leave a Comment
Comments (0)